Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Zootaxa|April 2, 2020
Description of a new Peronia species (Gastropoda: Eupulmonata: Onchidiidae) from Iran, Persian GulfFatemeh Maniei, Marianne Espeland, Mohammad Movahedi, et al.Saudi Medical Journal|November 8, 2011
Study of risky behaviors leading to unintentional injuries among high school students in Tehran, IranElaheh Ainy, Mohammad Movahedi, Abass Aghaei, et al.Plos One|September 7, 2022
Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohortMohammad Movahedi, Angela Cesta, Xiuying Li, et al.Journal of Clinical Epidemiology|June 22, 2019
Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative-a rheumatoid arthritis cohortMohammad Movahedi, Angela Cesta, Xiuying Li, et al.Therapeutic Advances in Musculoskeletal Disease|March 1, 2021
Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomesKangping Cui, Mohammad Movahedi, Claire Bombardier, et al.Arthritis Research & Therapy|November 19, 2022
Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research InitiativeXiuying Li, Angela Cesta, Mohammad Movahedi, et al.Clinical and Experimental Rheumatology|June 29, 2023
Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research InitiativePooneh S Akhavan, Mohammad Movahedi, Angela Cesta, et al.ACR Open Rheumatology|March 15, 2020
Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid ArthritisMohammad Movahedi, Deborah Weber, Pooneh Akhavan, et al.ACR Open Rheumatology|November 17, 2023
Cardiovascular Risk Factors and the Risk of Discontinuation of Advanced Therapies Due to Treatment Failure in Rheumatoid Arthritis: Results From the Ontario Best Practices Research InitiativeSamar Aboulenain, Xiuying Li, Mohammad Movahedi, et al.Clinical and Experimental Rheumatology|February 19, 2024
Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registryNancy Guo, Xiuying Li, Mohammad Movahedi, et al.Pageof 6